| 1 | Ordinary | Adoption of standalone and consolidated financial statements for the year ended 31 March 2024 |  |
| 2 | Ordinary | Declare dividend of Rs. 40.0 per equity share (face value of Rs. 5.0) for FY24 | |
| 3 | Ordinary | Reappoint K Satish Reddy (DIN: 00129701) as Director, liable to retire by rotation | |
| 4 | Ordinary | Approve appointment of Vishal Reddy as an entry level employee at Dr. Reddy’s Laboratories Inc. USA, a wholly owned subsidiary (office of profit position) for five years | |
| 5 | Ordinary | Approve remuneration of Rs. 900,000 to Sagar & Associates as cost auditors for FY25 | |
July 29, 2024, 11 a.m.